MyFinsight
Home
Blog
About
Contact
Download
Download image
Net product revenue
$215,387K
Interest income
$5,757K
Net income
$32,488K
Acquired in-process
research & development...
$32,000K
Trade payables
$10,907K
Stock-based compensation
$10,620K
Intangible amortization
$5,961K
Other non-cash
expenses
$560K
Debt issuance costs
amortization
$151K
Inventory
-$76K
Canceled cashflow
$188,656K
Net cash provided by
operating activities
$27,760K
Canceled cashflow
$65,023K
Cost of product sold
$44,505K
Research and development
$35,018K
Other segment items
$32,127K
Sales and marketing
$29,899K
General and
administrative
$20,398K
Stock-based compensation
$10,308K
Income tax expense
$7,199K
Depreciation and
amortization
$5,968K
Interest expense
$3,234K
Net (decrease)
increase in cash, cash...
-$163,104K
Canceled cashflow
$27,760K
Proceeds from maturities
and sales of...
$27,349K
Proceeds from exercised
options
$347K
Other liabilities
-$46,184K
Trade receivables
$11,435K
Deferred taxes
-$3,863K
Prepaid expenses and
other assets
$2,996K
Stock appreciation
rights market...
-$312K
Amortization of premiums and
accretion of discounts on...
$220K
Depreciation
-$13K
Net cash (used in)
provided by investing...
-$183,646K
Canceled cashflow
$27,349K
Net cash used in
financing activities
-$7,218K
Canceled cashflow
$347K
Purchase of investment
securities
$178,995K
Payment of upfront fee
related to license...
$32,000K
Principal repayment of
long-term debt
$5,000K
Payments of employee
withholding taxes related to...
$2,565K
Back
Back
Cash Flow
Harmony Biosciences Holdings, Inc. (HRMY)
Harmony Biosciences Holdings, Inc. (HRMY)
source: myfinsight.com